Sanofi SA (EPA: SAN) is in focus today after teaming up with OpenAI to deploy artificial intelligence for drug development.
French drugmaker Sanofi on Tuesday announced it is collaborating with artificial intelligence company OpenAI and Formation ...
French pharmaceutical company Sanofi announced Tuesday a partnership with ChatGPT-founder OpenAI and US biotech firm ...
Le laboratoire pharmaceutique français Sanofi a annoncé une collaboration avec OpenAI, la société qui a lancé ChatGPT.
Sanofi CEO Paul Hudson thinks AI offers 'insane' potential for the pharmaceutical industry, which can spend up to $4 billion ...
Sanofi-Résultats positifs dans le traitement de l'asthme avec le rilzabrutinib 22/05 RE SANOFI - LES RÉSULTATS SOUTIENNENT LE DÉVELOPPEMENT ET L'AVANCEM… 22/05 RE Sanofi : s'allie à OpenAI ...
French drugmaker Sanofi SA (NASDAQ:SNY) announced its collaboration with OpenAI and Formation Bio to accelerate drug ...
Sanofi said in a statement that the partnership with OpenAi will allow it to access proprietary data to develop AI models for its biopharma models, while Formation Bio will provide additional ...